Efficacy and Safety of Solifenacin in Male Patients: Results of the Non-Interventional Study "Male Overactive Bladder on Vesicare: MOVE"

被引：0
|
作者：
Hampel, C. [1 ]
Burger, M. [2 ]
Betz, D. [3 ]
Vogel, M. [4 ]
机构：
[1] Johannes Gutenberg Univ Mainz, Dept Urol, Univ Med Ctr, Mainz, Germany
[2] Univ Wurzburg, Dept Urol, Wurzburg, Germany
[3] Ctr Urol, Ratingen, Germany
[4] Astellas Pharma Germany, Munich, Germany
来源：
UROLOGY | 2012年 / 80卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP-12.17
引用
收藏
页码：S123 / S124
页数：2
相关论文
共 50 条
  • [41] Long-term safety and efficacy of mirabegron and solifenacin in combination compared with monotherapy in patients with overactive bladder: SYNERGY II study
    Alcantara Montero, A.
    ACTAS UROLOGICAS ESPANOLAS, 2019, 43 (01): : 51 - 52
  • [42] Anticholinergic burden and comorbidities in patients attending treatment with trospium chloride for overactive bladder in a real-life setting: results of a prospective non-interventional study
    Ivchenko, A.
    Boedeker, R-H.
    Neumeister, C.
    Wiedemann, A.
    BMC UROLOGY, 2018, 18
  • [43] Efficacy and Safety of Mirabegron Add-on Therapy After Failure With Solifenacin in Multiple Sclerosis Patients With Overactive Bladder: A Pilot Study
    Mut, Senem Ertugrul
    Selcuk, Ferda
    Incirli, Sila Usar
    Delibas, Sedef
    CLINICAL NEUROPHARMACOLOGY, 2024, 47 (04) : 109 - 112
  • [44] TOLERABILITY OF SOLIFENACIN IN COMPARISON WITH OXYBUTYNIN IMMEDIATE RELEASE IN PATIENTS WITH OVERACTIVE BLADDER: RESULTS OF THE VECTOR STUDY
    Herschorn, Sender
    Pommerville, Peter
    Stothers, Lynn
    Egerdie, Blair
    Gajewski, Jerzy
    Carlson, Kevin
    Radomski, Sidney
    Drutz, Harold
    Schulz, Jane
    Barkin, Jack
    Hirshberg, Eric
    Corcos, Jacques
    JOURNAL OF UROLOGY, 2009, 181 (04): : 557 - 557
  • [45] Results of the non-interventional TARGET study - Efficacy and safety of nilotinib in routine healthcare: Management of CML patients failing prior therapy
    le Coutre, P.
    Mueller, M. C.
    Stegelmann, F.
    Ulshoefer, T.
    Sauer, A.
    Reichert, D.
    Schwinger, U.
    Waller, C.
    Schardt, C.
    Losem, C.
    Schneider-Kappus, W.
    Stern, S.
    Vehling-Kaiser, U.
    Meincke, M.
    Frank, O.
    Dengler, J.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 115 - 115
  • [46] Efficacy and safety of tetrabenazin in treatment of tardive dyskinesia results of a multicentric non-interventional trial
    Dose, Matthias
    Gawora, Karin
    PSYCHOPHARMAKOTHERAPIE, 2009, 16 (05): : 203 - +
  • [47] Final Results from a Non-Interventional Safety and Efficacy Study of a VWF/FVIII Concentrate (wilate®) in Patients with Von Willebrand Disease
    Yaish, Hassan M.
    Cruz, Maria Sol
    Decker, Kay
    Zetterberg, Eva M. K.
    Werner, Sylvia
    Hashimoto, Mariko
    Knaub, Sigurd
    Rodgers, George M.
    BLOOD, 2018, 132
  • [48] Safety and efficacy of pdVWF/FVIII in patients with von Willebrand disease undergoing surgery: Results from a non-interventional multicentre study
    Khair, K.
    Prondzinski, M. von Depka
    Sholzberg, M.
    Cruz, M. Sol
    Decker, K.
    Cermakova, Z.
    Werner, S.
    Rodgers, G.
    HAEMOPHILIA, 2019, 25 : 179 - 180
  • [49] Results of the non-interventional TARGET study: Efficacy and safety of nilotinib in CML patients (pts) failing prior therapy in routine healthcare
    Dengler, J.
    Mueller, M. C.
    Buss, E.
    le Coutre, P.
    Stegelmann, F.
    Ulshoefer, T.
    Sauer, A.
    Schardt, C.
    Reichert, D.
    Schwinger, U.
    Grunewald, R.
    Waller, C.
    Meincke, M.
    Rupprecht, S.
    Tesch, H.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 56 - 56
  • [50] A Prospective, non-intErventional Registry Study of PatiEnts initiating a Course of drug Therapy for overactIVE bladder (PERSPECTIVE): Rationale, design, and methodology
    Rovner, Eric S.
    Carlson, Kevin, V
    Deal, Anna S.
    Nair, Kavita, V
    Oakkar, Eva E.
    Park, Julie
    Gemmen, Eric
    Kristy, Rita M.
    Gooch, Katherine L.
    Schermer, Carol R.
    CONTEMPORARY CLINICAL TRIALS, 2018, 70 : 83 - 87
12345